Login / Signup

Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.

Marco FornaroVincenzo VeneritoFlorenzo IannoneFabio Cacciapaglia
Published in: The Journal of rheumatology (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • free survival
  • binding protein